Na Zhao

机构：Shandong University of Aeronautics, Army Medical University, China Pharmaceutical University, SGIDI Engineering Consulting (China), Yantaishan Hospital · ORCID：0000-0002-3086-2993

发表论文 28 篇 · 总被引 802 次 · h-index 10

代表论文

• Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials (2015 · American Journal of Kidney Diseases · 被引 489)
• The Red Blood Cell Distribution Width–Albumin Ratio: A Promising Predictor of Mortality in Stroke Patients (2021 · International Journal of General Medicine · 被引 96)
• The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis (2023 · Frontiers in Immunology · 被引 34)
• Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents (2021 · Proceedings of the National Academy of Sciences · 被引 32)
• [Risk factors and early diagnosis of acute kidney injury in patients with sepsis]. (2013 · PubMed · 被引 27)
• Red cell distribution width is associated with all-cause mortality in patients with acute stroke: a retrospective analysis of a large clinical database (2021 · Journal of International Medical Research · 被引 23)